Clinical Risk Grouping Solutions Market Size
Study Period | 2019 - 2029 |
Market Size (2024) | USD 0.72 Billion |
Market Size (2029) | USD 1.41 Billion |
CAGR (2024 - 2029) | 14.48 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Clinical Risk Grouping Solutions Market Analysis
The Clinical Risk Grouping Solutions Market size is estimated at USD 0.72 billion in 2024, and is expected to reach USD 1.41 billion by 2029, growing at a CAGR of 14.48% during the forecast period (2024-2029).
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care. Besides, accuracy in risk assessment and growing investments in R&D of new therapeutics is anticipated to boost the market growth over the forecast period. Furthermore, the compilation of patient information in a healthcare setting, resulting in physician burden, increases the demand for clinical risk grouping solutions.
However, lack of skilled professionals, concerns regarding the private cloud data management, and high costs related to management solutions are projected to hamper the market growth over the forecast period.
Clinical Risk Grouping Solutions Market Trends
This section covers the major market trends shaping the Clinical Risk Grouping Solutions Market according to our research experts:
Dashboard and Data Visualisation Tools are Anticipated to Grow at Significant Rate
Dashboard and data visualization tools are anticipated to grow at notable rates owing to its ability to predict the payment process and predict payment risk. Besides, increasing the need to reduce healthcare costs coupled with the increasing adoption of big data is anticipated to boost the market growth over the forecast period. Moreover, the adoption of cloud-based technologies to manage clinical data and the growing prevalence of chronic diseases is expected to fuel market growth.
The hospital segment is anticipated to have notable market growth owing to increasing adoption of big data, growing focus of caregivers in risk management solution, increasing investment in infrastructure to enhance the healthcare facilities to improve the care.
North America Expected to Have Significant Market Growth
Among the regional segment, North America is expected to have significant market growth over the forecast period. This growth is attributed to the growing prevalence of chronic diseases, well-established healthcare infrastructure, and the high adoption of advanced technologies and government initiatives to mandate health records maintenance.
However, the Asia Pacific region is projected to have lucrative market growth opportunities due to the presence of a large pool of patient populations, increasing need for better risk management solutions, adoption of recording and maintaining the health records, and growing prevalence of chronic diseases.
Clinical Risk Grouping Solutions Industry Overview
The global clinical risk grouping market is moderately consolidated and competitive. Market players are focusing on new product launches, product innovations, and geographical expansion. F. The key market players operating in the market include 3M Company, Optum Inc., Conduent Inc., Lightbeam Health Solutions, and Health Catalyst.
Clinical Risk Grouping Solutions Market Leaders
-
3M Company
-
Optum Inc.
-
Conduent Inc.
-
Lightbeam Health Solutions
-
Health Catalyst
*Disclaimer: Major Players sorted in no particular order
Clinical Risk Grouping Solutions Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Demand for Clinical Risk Management and Adoption of Big Data in Healthcare
-
4.2.2 Advancements in Data Management to Improve the Clinical Operations
-
-
4.3 Market Restraints
-
4.3.1 Concerns Regarding the Private Cloud Data Breaches
-
4.3.2 High Cost Related to Clinical Solutions
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Deployment
-
5.1.1 Public Cloud
-
5.1.2 Private Cloud
-
5.1.3 Hybrid Cloud
-
-
5.2 By Product
-
5.2.1 Dashboard Analytics
-
5.2.2 Scorecard and Data Visualization Tools
-
5.2.3 Risk Reporting Solutions
-
-
5.3 By End User
-
5.3.1 Pharmaceuticals
-
5.3.2 Clinical Research organizations
-
5.3.3 Other End User
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle East & Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle East & Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 3M Company
-
6.1.2 Optum Inc.
-
6.1.3 Conduent Inc.
-
6.1.4 Lightbeam Health Solutions
-
6.1.5 Health Catalyst
-
6.1.6 HBI Solutions
-
6.1.7 Dynamic Healthcare Systems Inc.
-
6.1.8 4S Information Systems Ltd
-
6.1.9 Evolent Health Inc.
-
6.1.10 PeraHealth Inc.
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Clinical Risk Grouping Solutions Industry Segmentation
As per the report's scope, clinical risk grouping refers to the classification system for risk adjustment that assigns each individual to different risk groups based on historical data and demographic characters for future projections.
By Deployment | |
Public Cloud | |
Private Cloud | |
Hybrid Cloud |
By Product | |
Dashboard Analytics | |
Scorecard and Data Visualization Tools | |
Risk Reporting Solutions |
By End User | |
Pharmaceuticals | |
Clinical Research organizations | |
Other End User |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Clinical Risk Grouping Solutions Market Research FAQs
How big is the Clinical Risk Grouping Solutions Market?
The Clinical Risk Grouping Solutions Market size is expected to reach USD 0.72 billion in 2024 and grow at a CAGR of 14.48% to reach USD 1.41 billion by 2029.
What is the current Clinical Risk Grouping Solutions Market size?
In 2024, the Clinical Risk Grouping Solutions Market size is expected to reach USD 0.72 billion.
Who are the key players in Clinical Risk Grouping Solutions Market?
3M Company, Optum Inc., Conduent Inc., Lightbeam Health Solutions and Health Catalyst are the major companies operating in the Clinical Risk Grouping Solutions Market.
Which is the fastest growing region in Clinical Risk Grouping Solutions Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Clinical Risk Grouping Solutions Market?
In 2024, the North America accounts for the largest market share in Clinical Risk Grouping Solutions Market.
What years does this Clinical Risk Grouping Solutions Market cover, and what was the market size in 2023?
In 2023, the Clinical Risk Grouping Solutions Market size was estimated at USD 0.63 billion. The report covers the Clinical Risk Grouping Solutions Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Clinical Risk Grouping Solutions Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Clinical Risk Grouping Solutions Industry Report
Statistics for the 2024 Clinical Risk Grouping Solutions market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Clinical Risk Grouping Solutions analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.